Sca-1+ cells from mouse fetal liver can differentiate into neurons in vitro

AIM: To study whether Sca-1⁺ cells from fetal liver can be induced to differentiate into neuronal cells in vitro. METHODS:Sca-1⁺cells from 14 5-days-old murine fetal liver were isolated with a magnetic cell sorting kit, and were cultured in Dulbecco s modif ied Eagle s medium(DMEM)/F12 supplemented with 10%fetal bovine serum(FBS), and passaged at a rat io of 1 3 when cells reached more than 80%confluence.The 5 passage cells were induced by 10^-3mol/Lβ-mercaptoethanol(β-ME)and 5×10^-7 mol/L all-trans-retinoic acid(RA)for 24 hours, and then incubated in serum-free medium for 5 hours to 5 days.The characteristics of treated cel s were assayed by immunocytochemistry staining analysis at 5 hours, or 5 days.RESULTS: Cells treated with β-ME and RA exhibited neuronal phenotype and expressed neuron-specific protein such as neuron-specific nuclear protein (NeuN), neuronfilament-M, and neuron-specific tubulin-1 (TuJ-1) but not tau, MAP-2, or the astrocyte-specific marker glial fibrillary acidic protein (GFAP).CONCLUSION: Sca-1⁺ cells from fetal liver, of which most are regarded as hematopoietic stem cells, could differentiate into early immature neuronal cells in vitro. These findings suggest that Sca-1⁺ cells from fetal liver may be an alternative source in cell therapy and gene therapy of neural dysfunction.     

Serum contents of E-selectin,sICAM-1, sVCAM-1 in patients with acute coronary syndrome

AIM:To explore the serum levels of certain adhesion molecules and its significance in acute coronary syndrome(ACS). METHODS:The subjects included 40 patients with acute myocardial infarction(AMI) and 40 patients with unstable angina pectoris (UAP). Among the 80 patients, 60 patients accepted a follow-up 4 months. At the same time we selected 40 controls from people who attended a routine health check in the university. Serum levels of E-selectin, sICAM-1, sVCAM-1 were measured by ELISA.RESULTS:Serum levels of E-selectin, sICAM-1, sVCAM-1 were significantly higher in the ACS group(AMI or UAP) than in the control group. Four months later, the levels of E-selectin, sICAM-1 became significantly lower in the follow-up group than in the ACS group, while sVCAM-1 showed no significant difference. CONCLUSION:Serum levels of E-selectin, sICAM-1 may have certain diagnostic value for ACS, and can be a useful marker reflecting the stability of the disease.     

早熟春大白菜新品种三园春皇的选育

从北京、天津引进的大白菜品种中选育出两个自交不亲和系 90 2和 90 7,继而配制成春大白菜一代杂种三园春皇。该品种早熟 ,生长期 6 0～ 6 5d(天 ) ;一般 6 6 7m2 产量 40 0 0～ 6 0 0 0kg ,比对照鲁春白 1号增产16 % ;抗病毒病和霜霉病 ,对软腐病的抗性与对照相近 ;叶球橄榄形 ,质地脆嫩 ,品质优良。单球质量 2～ 2 .5kg     

干椒新品种蓉椒6号的选育

自交系9804和9909杂交配制成杂交一代干椒，植株生长旺盛，座果力强，较抗病毒病和疫病，果实指形，纵长17～19cm，横径1．2cm，青熟果绿色，老熟果鲜红色，单果重8．3g，味辣，品质佳，中熟品种，从定植到采收55d(天)，一般每667m^2产1500～1900kg。     

吡啶衍生物研究(IX):N-(1-甲氧羰基)乙基-N-[5-(2-氯吡啶-4-基)-1,3,4-噻二唑-2-基]酰胺的合成及除草活性

为了进一步研究前期发现的除草先导化合物2-仲丁氨基-5-(2-氯吡啶-4-基)-1，3，4-噻二唑(BCPT)的结构-活性关系并提高其除草活性，设计并合成了一系列N-(1-甲氧羰基)乙基-N-[5-(2-氯吡啶-4-基)-1，3，4-噻二唑-2-基]酰胺类化合物。其苗后除草活性测定结果表明，所有化合物的活性都远低于BCPT本身。说明BCPT可能具有与传统酰胺类除草剂不同的作用机制。     

披碱草和野大麦杂种F1与BC1F1代的生物学及农艺特性研究

对披碱草和野大麦及其杂种F1与BC1F1代的生物学及农艺特性进行了分析比较。结果表明,亲本野大麦生长发育节律较快,较早地开花结实,果后营养期较长,生育期74d,生长天数达206d,具有很强的分蘖能力;披碱草生长发育节律较慢,生育期124d,生长天数193d;杂种F1的生长天数介于双亲之间,生长动态偏向亲本披碱草,分蘖能力介于双亲之间;BC1F1代生长发育节律较F1代提早,不同株系生长天数不同,生长动态偏向轮回亲本野大麦,分蘖能力有较大的变异。杂种F1代表现出较强的杂种优势,BC1F1代产草量较F1代有所降低,不同株系间存在明显的差异。总体上,BC1F1代的生产性能倾向于轮回亲本野大麦。     

水稻无盘旱育免耕抛秧不同密度试验

为了探索水稻无盘旱育免耕抛秧适宜栽培密度和技术,设计了6种不同抛秧密度的试验。结果表明,性状指标变化情况为:株高、穴穗数、穗长、穗总粒数、穗实粒数随抛秧密度的增加而减少,667m2穗数随抛秧密度的增加而增加,够苗期随密度的增加而提前,其他性状指标变化不大。667m2抛秧14 000、17 000和20 000粒谷秧的处理4、5、6产量较高,分别为760.3 kg/667m2、718.2 kg/667m2和712.8 kg/667m2,与其余3个处理间达显著或极显著水平。无盘旱育免耕抛秧适宜的密度范围为1 4 000~20 000粒谷秧/667m2。     

马铃薯品种黔芋一号高产配套技术措施研究

采用二因素饱和D最优设计对黔芋一号施肥水平(氮、磷、钾固定比例2∶1∶4)、密度2个主要栽培措施进行了试验研究。结果表明,在中等土壤肥力条件下要获得1 900~2 250 kg/667m2的产量,可以采用施肥水平在13.96~16.98 kg/667m2与密度3 574~4 200株/667m2的组合方案;要获得大于2250 kg/667m2的产量,施肥水平应在14.98~16.57 kg/667m2,密度在4 200~4 884株/667m2为宜。     

携带猪流行性腹泻病毒S1抗原表位的乙肝核心抗原病毒样颗粒的构建与鉴定

旨在构建以乙肝核心抗原(HBcAg)为载体呈现猪流行性腹泻病毒(PEDV)S1抗原表位的病毒样颗粒.将PEDV S1蛋白中含B细胞表位的270 bp片段插入到HBcAg主要免疫显性区域(MIR),构建重组质粒pET-32a(+)-HBcAg-PEDV S1,转化到感受态细胞BL21(DE3)中,经IPTG诱导表达,SD...